MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG
A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I): where X is S, O...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | ger |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DOWEYKO, ARTHUR M YANG, BINGWEI VERA DOWEYKO, LIDIA M |
description | A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I): where X is S, O or N; Z is -T-COOR1 or -T-COR1; and T, R, R1, Ra, Rb, Rc, Rd, Z, A and B are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE499350TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE499350TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE499350TT13</originalsourceid><addsrcrecordid>eNrjZIj19XcJ9XEM8Q9y9VNwcQ1ScPcJdfZ39g8K8XT293QJco1yDQBK6uooOAboGuoqhPq56PuD1Pm56Xo76Tp6h3iGeYYcbgkByYAMABoT5hoU7urnEurnzsPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4h1DXE0sLY1NDUJCDI2JUQMARLcz3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG</title><source>esp@cenet</source><creator>DOWEYKO, ARTHUR M ; YANG, BINGWEI VERA ; DOWEYKO, LIDIA M</creator><creatorcontrib>DOWEYKO, ARTHUR M ; YANG, BINGWEI VERA ; DOWEYKO, LIDIA M</creatorcontrib><description>A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I): where X is S, O or N; Z is -T-COOR1 or -T-COR1; and T, R, R1, Ra, Rb, Rc, Rd, Z, A and B are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.</description><language>ger</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110315&DB=EPODOC&CC=AT&NR=E499350T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110315&DB=EPODOC&CC=AT&NR=E499350T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DOWEYKO, ARTHUR M</creatorcontrib><creatorcontrib>YANG, BINGWEI VERA</creatorcontrib><creatorcontrib>DOWEYKO, LIDIA M</creatorcontrib><title>MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG</title><description>A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I): where X is S, O or N; Z is -T-COOR1 or -T-COR1; and T, R, R1, Ra, Rb, Rc, Rd, Z, A and B are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIj19XcJ9XEM8Q9y9VNwcQ1ScPcJdfZ39g8K8XT293QJco1yDQBK6uooOAboGuoqhPq56PuD1Pm56Xo76Tp6h3iGeYYcbgkByYAMABoT5hoU7urnEurnzsPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4h1DXE0sLY1NDUJCDI2JUQMARLcz3Q</recordid><startdate>20110315</startdate><enddate>20110315</enddate><creator>DOWEYKO, ARTHUR M</creator><creator>YANG, BINGWEI VERA</creator><creator>DOWEYKO, LIDIA M</creator><scope>EVB</scope></search><sort><creationdate>20110315</creationdate><title>MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG</title><author>DOWEYKO, ARTHUR M ; YANG, BINGWEI VERA ; DOWEYKO, LIDIA M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE499350TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>DOWEYKO, ARTHUR M</creatorcontrib><creatorcontrib>YANG, BINGWEI VERA</creatorcontrib><creatorcontrib>DOWEYKO, LIDIA M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DOWEYKO, ARTHUR M</au><au>YANG, BINGWEI VERA</au><au>DOWEYKO, LIDIA M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG</title><date>2011-03-15</date><risdate>2011</risdate><abstract>A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I): where X is S, O or N; Z is -T-COOR1 or -T-COR1; and T, R, R1, Ra, Rb, Rc, Rd, Z, A and B are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | ger |
recordid | cdi_epo_espacenet_ATE499350TT1 |
source | esp@cenet |
title | MODULATOREN DER GLUCOCORTICOIDREZEPTOR-, AP-1- UND/ODER NF-KB-AKTIVITÄT UND DEREN VERWENDUNG |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A34%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DOWEYKO,%20ARTHUR%20M&rft.date=2011-03-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE499350TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |